Aradhana Sarin

Business Health Europe

AstraZeneca beats expectations

AstraZeneca's profits beat expectations as the company announced a new £300 million investment in the U.K.

2026 Another Catalyst Rich Year: AstraZeneca CFO Bloomberg — Apr 29, 18:13 PM
Astrazeneca ploughs £300m into UK in surprise U-turn City AM — Apr 29, 15:28 PM
AstraZeneca makes surprise U-turn with £300m pharma investment The Guardian — Apr 29, 12:15 PM
Astrazeneca tops expectations in the first quarter on strong cancer drug sales Associated Press — Apr 29, 12:06 PM
AstraZeneca posted stronger-than-expected profit and revenue on surging cancer drug sales Quartz — Apr 29, 12:00 PM
Shot in the arm for GSK and AstraZeneca from cancer drug sales The Argus — Apr 29, 11:25 AM
UK's biggest drugmakers see surprise profit bump, even as pharma grapples with U.S. policies CNBC — Apr 29, 09:32 AM
Shot in the arm for GSK and AstraZeneca from cancer drug sales The Standard — Apr 29, 11:21 AM
AstraZeneca to inject £300 million into UK in surprise U-turn The Independent — Apr 29, 13:24 PM
AstraZeneca recommits to £300mn UK investment Financial Times — Apr 29, 13:37 PM
AstraZeneca beats expectations on cancer drug demand RTE — Apr 29, 07:21 AM
AstraZeneca beats top-line and bottom-line estimates; reaffirms FY26 outlook Seeking Alpha — Apr 29, 06:43 AM
AstraZeneca Gets Revenue Boost From Cancer Drugs Wall Street Journal — Apr 29, 06:27 AM